en
Feature stories
5th annual Ride for the Cure
Thirty-eight brave and enthusiastic Novartis associates will hit the road again on September 19th for the 600 kilometer Toronto to Montreal Ride for the Cure to raise funds for breast cancer research.
Zambezi Expedition puts malaria in the spotlight
Novartis is part of a multi-agency partnership supporting an ambitious journey along the Zambezi River, highlighting the difficulty of delivering mosquito nets and malaria treatment to remote African communities.
NVGH blazes a trail: Effective and affordable vaccines for the developing world
Many eminent scientists are contributing to the Novartis Vaccines Institute for Global Health, the first research center established by a major vaccine manufacturer with a nonprofit mission - to discover and develop vaccines for “neglected” diseases of the developing world.
International Leprosy Congress in Hyderabad
Novartis and the Novartis Foundation for Sustainable Development are working toward the elimination of leprosy. “Toward a world without leprosy” was the motto of the 17th International Leprosy Congress in Hyderabad, India. A world free of leprosy is within reach.
ABOUT NOVARTIS
On March 7th, 1996 Sandoz and Ciba-Geigy, the two Swiss-based chemical/life sciences giants, became Novartis
Our Products
We are a leader in offering medicines to protect health, cure disease and improve well-being.